News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cytogen Corporation (CYTO) to Present at the Biotechnology Industry Organization (BIO) Investor Forum 2007


10/3/2007 10:56:11 AM

PRINCETON, N.J.--(BUSINESS WIRE)--Cytogen Corporation (NASDAQ: CYTO) today announced that Michael D. Becker, president and chief executive officer of Cytogen, is scheduled to present a corporate overview on Thursday October 11, 2007 at 3:00 pm pacific time (6:00 pm eastern time) at the BIO Investor Forum 2007. Mr. Becker’s presentation will include an update on CAPHOSOL prescription and shipment trends. CAPHOSOL® is an advanced electrolyte solution for the treatment of oral mucositis and dry mouth that Cytogen introduced in March 2007.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES